| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 05/06/2005 | CA2542720A1 Azabenzodiazepines as phosphodiesterase-4 inhibitors |
| 05/05/2005 | US20050096469 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide d1 receptor agonists |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/04/2005 | EP1337506A4 Improved process for production of gabapentin intermediate |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | CN1612876A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887884 For therapy of neurological and psychological disorders |
| 05/03/2005 | US6887883 Combating angiogenic activity in a human comprising administering to a chrysanthone compound |
| 04/28/2005 | WO2005037832A2 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005007630A3 Aryl fused azapolycyclic compounds |
| 04/28/2005 | US20050090539 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2539811A1 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone |
| 04/21/2005 | WO2004029028A3 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides as dyestuffs |
| 04/21/2005 | US20050085654 Metal coordination compound and electroluminescence device |
| 04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/20/2005 | EP1129077B1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 04/20/2005 | EP1042287B1 Indole derivatives as inhibitors of factor xa |
| 04/20/2005 | CN1608074A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 04/20/2005 | CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/19/2005 | US6881843 Process for production of gabapentin intermediate |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/14/2005 | WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/14/2005 | WO2004100891A3 Cytotoxic indeno and isoindoloisoquinolones |
| 04/14/2005 | US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/13/2005 | EP1521757A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 04/13/2005 | CN1196702C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 04/12/2005 | US6878825 Rylene derivatives and their use as dyes |
| 04/07/2005 | WO2005030791A2 Isoquinolinone potassium channel inhibitors |
| 04/07/2005 | US20050075453 Method for producing aqueous polymer dispersions containing colorants |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | CA2539444A1 Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with nk1 antagonistic activity |
| 04/06/2005 | EP1520856A1 Androgen receptor agonist |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519724A1 Fredericamycin derivatives as medicaments for treating tumours |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 03/31/2005 | WO2004089307A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 03/31/2005 | US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1194429B1 Potassium channel openers |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/24/2005 | WO2005026126A1 Crf antagonists and heterobicyclic compounds |
| 03/24/2005 | WO2005025572A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | WO2005025556A2 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 03/24/2005 | WO2005025507A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | US20050065338 Total synthesis of galanthamine, analogues and derivatives thereof |
| 03/24/2005 | CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | CA2538026A1 Crf antagonists and heterobicyclic compounds |
| 03/24/2005 | CA2537663A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | CA2537660A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | CA2534957A1 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 03/24/2005 | CA2530510A1 Improved delivery by labile hydrophobic modification of drugs |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | CN1599736A Process for the preparation of 4-(8-chloro-5, 6-dihydro-11h-benzo(5, 6)-cyclohepta-(1, 2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/10/2005 | WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
| 03/10/2005 | WO2002080150A8 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness |
| 03/10/2005 | CA2537123A1 New compounds |
| 03/09/2005 | EP1512683A1 Novel opiate compounds, methods of making and methods of use |
| 03/09/2005 | EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/09/2005 | EP1511517A1 Formulation for parenteral administration of sodium channel blockers |
| 03/09/2005 | EP1511487A1 Novel formulation for the parenteral application of crobenetine |
| 03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 03/08/2005 | US6864259 Antibacterial agents |
| 03/03/2005 | WO2005018561A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/03/2005 | WO2004086861A3 Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens |
| 03/03/2005 | US20050049270 6H,11H-Indole-[3,2-C]-Isoquinoline-5-one derivatives; nuclear enzyme poly (ADP-ribose) synthetase inhibitors; inflammatory and/or reperfusion diseases |
| 03/03/2005 | CA2536173A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1587260A Process for preparing high purity huperzine A |
| 02/24/2005 | WO2005016343A1 Novel anti-viral agents based upon derivatives of the aromatic heterocycle phenanthridine |
| 02/24/2005 | WO2004078712A3 Isoquinoline derivatives and methods of use thereof |
| 02/24/2005 | US20050043341 For stimulation of reverse cholesterol transport, lowering low density lipoproteins in blood; for treatment of hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, arteriosclerosis adiposity and obesity stroke or Alzheimer's disease |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/23/2005 | EP1507763A1 Tetrahydroisoquinoline derivatives |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1190425C Six kinds of isoquinoline alkaloid |
| 02/22/2005 | US6858622 Cycloalkano-indole and -azaindole derivatives |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | CN1580047A Aliphatic ester aconite alkaloid synthesizing method |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |